Author(s):
Adsul Samruddhi Subhash, Wable Madhuri Sanjay, Bhand Revannath Narayan, Gayke Sanket Ramesh, Prof . Prafulla Avhad
Email(s):
ushaadsul99@gmail.com
DOI:
10.52711/2231-5713.2026.00014 
Address:
Adsul Samruddhi Subhash, Wable Madhuri Sanjay, Bhand Revannath Narayan, Gayke Sanket Ramesh, Prof . Prafulla Avhad
Swastyadarpan Pratishthan’s Shantiniketan College of Pharmacy, A/P Dhotre (B.K.), Tal.Parner, Ahmednagar, Maharastra – 414304.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
Oral drug delivery remains the most widely accepted route of administration due to its cost-effectiveness, ease of use, patient compliance, and flexibility in dosage forms. However, it is often limited by rapid gastrointestinal transit, short gastric residence time, and poor bioavailability of certain drugs. To address these challenges, Floating Drug Delivery Systems (FDDS) have emerged as a promising gastro-retentive approach. FDDS, first introduced by Davis in 1968, are designed to remain buoyant in gastric fluids, thereby prolonging gastric residence time and ensuring controlled release of drugs at the site of absorption. These systems are particularly advantageous for drugs with a narrow absorption window in the upper gastrointestinal tract, high solubility in acidic pH, or instability in alkaline or colonic environments. The formulations employ excipients such as hydrocolloids, polymers, effervescent agents, fatty materials, and release modifiers to maintain buoyancy and regulate drug release. Depending on the design, FDDS may be classified as effervescent, non-effervescent, raft-forming, hydrodynamically balanced, or multi-unit systems. Numerous drugs, including anti-ulcer agents, antibiotics, antihypertensives, and antidiabetics, have been successfully formulated into floating systems. While FDDS provide sustained release, improved bioavailability, and reduced dosing frequency, limitations include dependence on gastric motility, fluid level, and patient variability. Recent advances such as floating microspheres, super-porous hydrogels, and 3D-printed personalized systems highlight the potential of FDDS in modern therapeutics. Future perspectives focus on integrating nanotechnology and smart polymers to further enhance site-specific drug delivery and patient outcomes.
Cite this article:
Adsul Samruddhi Subhash, Wable Madhuri Sanjay, Bhand Revannath Narayan, Gayke Sanket Ramesh, Prof . Prafulla Avhad. Floating Drug Delivery Systems: An Advanced Approach for Oral Controlled Drug Release. Asian Journal of Pharmacy and Technology. 2026; 16(1):99-4. doi: 10.52711/2231-5713.2026.00014
Cite(Electronic):
Adsul Samruddhi Subhash, Wable Madhuri Sanjay, Bhand Revannath Narayan, Gayke Sanket Ramesh, Prof . Prafulla Avhad. Floating Drug Delivery Systems: An Advanced Approach for Oral Controlled Drug Release. Asian Journal of Pharmacy and Technology. 2026; 16(1):99-4. doi: 10.52711/2231-5713.2026.00014 Available on: https://ajptonline.com/AbstractView.aspx?PID=2026-16-1-14
REFERANCES:
1. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics. 2002 Aug; 41(9):661-80.
2. Gupta PK, Robinson JR. Oral controlled-release delivery. Treatise on Controlled Drug Delivery. 2017 Oct 2: 255-313.
3. Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Delivery. 2011 Feb 1; 18(2): 97-110.
4. Kamini KM, Pooni N, Singh M, Verma K, Dhiman N, Sharma N, Bhandari N. Floating Drug Delivery System:-A Review. WJ Pharm. P’ceutical. Sci. 2017. 2017 Jan 30; 6(4): 578-94.
5. Bhardwaj V, Harikumar SL. Floating drug delivery system: A review. Pharmacophore. 2013; 4(1-2013): 26-38.
6. Raikwar S, Jain SK. Gastrointestinal absorption of drugs. InPhysico-Chemical Aspects of Dosage Forms and Biopharmaceutics 2024 Jan 1 (pp. 147-164). Academic Press.
7. Reddy LH, Murthy RS. Floating dosage systems in drug delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2002; 19(6).
8. Das S, Kaur S, Rai VK. Gastro-retentive drug delivery systems: A recent update on clinical pertinence and drug delivery. Drug Delivery and Translational Research. 2021 Oct; 11(5): 1849-77.
9. Davis SS. Formulation strategies for absorption windows. Drug discovery today. 2005 Feb 15; 10(4): 249-57.
10. Rajendra BA, SJ V, CR S. A comprehensive review on floating drug delivery system (FDDS). Res J Pharm Biol Chem Sci. 2020; 10(6): 174-82
11. .Hellström PM, Grybäck P, Jacobsson H. The physiology of gastric emptying. Best Practice & Research Clinical Anaesthesiology. 2006 Sep 1; 20(3): 397-407.
12. Sharma N, Agarwal D, Gupta MK, Khinchi M. A comprehensive review on floating drug delivery system. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011 Apr; 2(2): 428-41.
13. Zaman R, Islam RA, Ibnat N, Othman I, Zaini A, Lee CY, Chowdhury EH. Current strategies in extending half-lives of therapeutic proteins. Journal of Controlled Release. 2019 May 10; 301: 176-89
14. Geraili A, Xing M, Mequanint K. Design and fabrication of drug‐delivery systems toward adjustable release profiles for personalized treatment. View. 2021 Oct; 2(5): 20200126..
15. Dixit N. Floating drug delivery system. Journal of Current Pharmaceutical Research. 2011; 7(1): 6-20.
16. Foody GM. Latent class modeling for site-and non-site-specific classification accuracy assessment without ground data. IEEE Transactions on Geoscience and Remote Sensing. 2011 Dec 19; 50(7): 2827-38.
17. Mayersohn M. Principles of drug absorption. InModern Pharmaceutics Volume 1 2009 May 28 (pp. 41-98). CRC Press.
18. Pandey A, Mishra S, Tiwari A, Misra K. Targeted drug delivery (Site specific drug delivery). Journal of Scientific and Industrial Research. 2004 Mar 1; 63(3): 230-47.
19. Shah K, Singh D, Agrawal R, Garg A. Current developments in the delivery of gastro-retentive drugs. AAPS PharmSciTech. 2025 Feb 7; 26(2): 57.
20. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Development and Industrial Pharmacy. 1996 Jan 1; 22(6): 531-9.
21. Sim DS. Drug absorption and bioavailability. InPharmacological basis of acute care 2014 Oct 7 (pp. 17-26). Cham: Springer International Publishing.
22. Holford NH. Pharmacokinetics & Pharmacodynamics: rational dosing and the time course of drug action. Basic & Clinical Pharmacology. 2009; 13.
23. Gupta A, Shetty S, Mutalik S, Mathew EM, Jha A, Mishra B, Rajpurohit S, Ravi G, Saha M, Moorkoth S. Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation. Heliyon. 2023 Oct 1; 9(10).
24. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997 Oct 1; 20(10):1512-7.
25. Wüstenberg T. General overview of food hydrocolloids. Cellulose and Cellulose Derivatives in the Food industry Fundamentals and Applications; Wüstenberg, T., Ed. 2015:1-68.
26. Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, García-Martín MG, de-Paz MV. In-depth study into polymeric materials in low-density gastroretentive formulations. Pharmaceutics. 2020 Jul 7; 12(7):636.
27. Ali MN, Malek A, Akter P, Al Juhan A, Safrin F, Akter F. A Comprehensive Review on Floating Drug Delivery System. Saudi J Med Pharm Sci. 2025; 11(5):383-93.
28. Gunda RK, Vijayalakshmi A. Formulation development and evaluation of gastro retentive drug delivery systems-a review. J Pharm Res. 2017 Feb 27; 11:167-78.
29. Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?. Pharmaceutical Development and Technology. 2014 May 1; 19(3): 257-62.
30. McGinity JW, O'Donnell PB. Pharmaceuticals. InIndustrial Minerals and Their Uses 1996 Jan 1 (pp. 401-433). William Andrew Publishing.
31. Ishak RA. Buoyancy-generating agents for stomach-specific drug delivery: an overview with special emphasis on floating behavior. Journal of Pharmacy & Pharmaceutical Sciences. 2015 Mar 9; 18(1): 77-100.
32. Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. International Journal of Pharmaceutics. 2002 Jul 25; 241(2): 279-92.
33. Green JM, Beestman GB. Recently patented and commercialized formulation and adjuvant technology. Crop Protection. 2007 Mar 1; 26(3): 320-7.
34. Ishak RA. Buoyancy-generating agents for stomach-specific drug delivery: an overview with special emphasis on floating behavior. Journal of Pharmacy & Pharmaceutical Sciences. 2015 Mar 9; 18(1):77-100.
35. Naseem F, Shah SU, Rashid SA, Farid A, Almehmadi M, Alghamdi S. Metronidazole based floating bioadhesive drug delivery system for potential eradication of H. pylori: preparation and in vitro characterization. Polymers. 2022 Jan 27; 14(3): 519.
36. Kumari PK, Sharmila M, Rao YS. Super porous hydrogels: a review. J. Pharm. Res. Int. 2020; 32: 153-65.
37. Domagała-Rodacka R, Cibor D, Szczeklik K, Rodacki T, Mach T, Owczarek D. Gastrointestinal tract as a side-effect target of medications.
38. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010 Aug 1; 59(8): 1143-53.
39. APRD00642 D, Renal E, S4 PO, Schedule IV CA IV S, Schedule IV. Physical properties.
40. Schwartz PA, Rhodes CT, Cooper Jr JW. Solubility and ionization characteristics of phenytoin. Journal of Pharmaceutical Sciences. 1977 Jul; 66(7):994-7.
41. Czarnetzki C, Elia N, Frossard JL, Giostra E, Spahr L, Waeber JL, Pavlovic G, Lysakowski C, Tramèr MR. Erythromycin for gastric emptying in patients undergoing general anesthesia for emergency surgery: a randomized clinical trial. JAMA Surgery. 2015 Aug 1; 150(8): 730-7.
42. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci. 2003 Jan 1; 6(1):33-66.
43. Gupta RK, Panda P, Kumar D. An Overview On The Analysis Of The Floating Drug Delivery System. World Journal of Pharmaceutical Research. 2024 Apr 16; 13(11):708-24.
44. Madhavi N. Comprehensive Review on Gastro Retentive Drug Delivery System.
45. Yeh YC, Huang TH, Yang SC, Chen CC, Fang JY. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Frontiers in Chemistry. 2020 Apr 24; 8: 286.
46. Vasave VS. A review on: floating drug delivery system. World J Pharmaceut Res. 2023; 12(2): 641-69.
47. Desai S, Bolton S. A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharmaceutical Research. 1993 Sep; 10(9): 1321-5.
48. Hou SY, Cowles VE, Berner B. Gastric retentive dosage forms: a review. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2003; 20(6).
49. Singh P, Joseph DD. Fluid dynamics of floating particles. Journal of Fluid Mechanics. 2005 May; 530:31-80.
50. Kotreka U, Adeyeye MC. Gastroretentive floating drug-delivery systems: a critical review. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2011; 28(1).
51. Rosensweig RE. Fluidmagnetic buoyancy. Aiaa Journal. 1966 Oct; 4(10): 1751-8.
52. Sreekanth Y. Formulation and Evaluation of Nizatiding Floatince Table (Doctoral dissertation, KK College of Pharmacy, Chennai).
53. Loira-Pastoriza C, Todoroff J, Vanbever R. Delivery strategies for sustained drug release in the lungs. Advanced Drug Delivery Reviews. 2014 Aug 30; 75:81-91.
54. Gatti G, Di Biagio A, Casazza R, De Pascalis C, Bassetti M, Cruciani M, Vella S, Bassetti D. The relationship between ritonavir plasma levels and side-effects: implications for therapeutic Drug Monitoring. Aids. 1999 Oct 22; 13(15): 2083-9.
55. Treuting PM, Arends MJ, Dintzis SM. Upper gastrointestinal tract. InComparative Anatomy and Histology 2018 Jan 1 (pp. 191-211). Academic Press.
56. Mathijssen RH, Sparreboom A, Verweij J. Determining the optimal dose in the development of anticancer agents. Nature reviews Clinical oncology. 2014 May; 11(5): 272-81.
57. Shin A. Disorders of gastric motility. The Lancet Gastroenterology & Hepatology. 2024 Nov 1; 9(11):1052- 64.
58. Timmermans J, Moës AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. Journal of Pharmaceutical Sciences. 1994 Jan; 83(1): 18-24
59. McQuaid KR. Drugs used in the treatment of gastrointestinal diseases. Basic & Clinical Pharmacology. 2018; 12..
60. Singh LD, Ganju DK, Amit B. Floating microsphere as novel approach drug delivery system. Asian Journal of Science and Technology. 2019 Sep; 10(09): 10103-12.
61. Niranjanbhai BD, Mahendrakumar VN, Surendran CS, Viral S, Upadhyay UM. Advances in grdds: raft forming system a review. Journal of Drug Delivery & Therapeutics. 2012; 2(5): 123-8.
62. Serrano DR, Kara A, Yuste I, Luciano FC, Ongoren B, Anaya BJ, Molina G, Diez L, Ramirez BI, Ramirez IO, Sánchez-Guirales SA. 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals. Pharmaceutics. 2023 Jan 17; 15(2): 313.
63. Naseem F, Shah SU, Rashid SA, Farid A, Almehmadi M, Alghamdi S. Metronidazole based floating bioadhesive drug delivery system for potential eradication of H. pylori: preparation and in vitro characterization. Polymers. 2022 Jan 27; 14(3): 519.
64. Alburyhi MM, Moharram BA. Formulation and Evaluation Of Aloe Niebuhriana Extract As Naturaceutical Effervescent Granules Novel Drug Delivery Systems For Antidiabetic Activity.
65. Başarır NS, Mesut B, Özsoy Y. A review on current perspective of gastroretentive drug delivery systems prioritising floating dosage forms. Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2021; 4(2): 43-64.
66. Shelar SN. Development and evaluation of floating microspheres of ketoprofen (Master's thesis, Rajiv Gandhi University of Health Sciences (India)).
67. Garg T, Kumar A, Rath G, Goyal A. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2014; 31(6).
68. Rao NR, Sheela MA, Maurya MA, Ali MI. Molecular pharmaceutics (nano technology & targeted dds). Jec publication; .
69. Biomaterials Science, Polymer Edition. 2008 Jan 1; 19(6): 755-67.
70. Alzoubi L, Aljabali AA, Tambuwala MM. Empowering precision medicine: the impact of 3D printing on personalized therapeutic. Aaps Pharmscitech. 2023 Nov 14; 24(8): 228.
71. Vaniprasanna T, Traitel T, Goldbart R, Kost J. Smart polymers for responsive drug-delivery systems. Journal of Murthy TG, Rao AS. An Over View of Chronotherapeutic Drug Delivery Systems Based on Floating Pulsatile Concept. Drugs. 3:4.